TB-HAART trial
Lancet Infect Dis
.
2015 Jan;15(1):14-5.
doi: 10.1016/S1473-3099(14)71032-1.
Authors
Jason C Kwong
1
,
M Lindsay Grayson
2
Affiliations
1
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria 3084, Australia. Electronic address: kwongj@gmail.com.
2
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria 3084, Australia.
PMID:
25541161
DOI:
10.1016/S1473-3099(14)71032-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-HIV Agents / administration & dosage*
Antiretroviral Therapy, Highly Active / methods*
Female
HIV Infections / drug therapy*
Humans
Male
Tuberculosis, Pulmonary / drug therapy*
Substances
Anti-HIV Agents